Mechanisms underlying feed intolerance in the critically ill: Implications for treatment

doi:10.3748/wjg.v13.i29.3909

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4080)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

478

HTML

3363

Figures (1-3)

239

Sum=4080

Aug 7, 2007 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (99)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Aug 7, 2007; 13(29): 3909-3917
Published online Aug 7, 2007. doi: 10.3748/wjg.v13.i29.3909

Full Size Figure Download Figure

Figure 2 Kaplan Meier plots comparing the effects of erythromycin (200 mg IV BD) and metoclopramide (10 mg IV QID) in the treatment of feed intolerance. Significant tolerance developed to both drugs over 7 d. The combination of both drugs is effective rescue therapy[81].

Citation: Deane A, Chapman MJ, Fraser RJ, Bryant LK, Burgstad C, Nguyen NQ. Mechanisms underlying feed intolerance in the critically ill: Implications for treatment. World J Gastroenterol 2007; 13(29): 3909-3917
URL: https://www.wjgnet.com/1007-9327/full/v13/i29/3909.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i29.3909